InMed Pharmaceuticals

+$0.13 (+9.29%) Today
+$0.04 (+2.61%) As of 9:05 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INM and other ETFs, options, and stocks.

About INM

InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research and development of novel. It also involves in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids.

CEO
Eric A. Adams
Employees
—
Headquarters
Vancouver, British Columbia
Founded
1981

INM Key Statistics

Market Cap
17.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
436.44K
High Today
$1.77
Low Today
$1.50
Open Price
$1.51
Volume
4.21M
52 Week High
$8.94
52 Week Low
$1.38

INM Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Nov 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure